Engineered cationic antimicrobial peptide (eCAP) prevents Pseudomonas aeruginosa biofilm growth on airway epithelial cells

OBJECTIVES: Chronic infections with the opportunistic pathogen Pseudomonas aeruginosa are responsible for the majority of the morbidity and mortality in patients with cystic fibrosis (CF). While P. aeruginosa infections may initially be treated successfully with standard antibiotics, chronic infecti...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Antimicrob Chemother
Hoofdauteurs: Lashua, Lauren P., Melvin, Jeffrey A., Deslouches, Berthony, Pilewski, Joseph M., Montelaro, Ronald C., Bomberger, Jennifer M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2016
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4954927/
https://ncbi.nlm.nih.gov/pubmed/27231279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw143
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items